Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins - PubMed (original) (raw)
Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins
M Stevenson et al. Cancer Gene Ther. 2007 Apr.
Abstract
Effective gene therapy for disseminated metastatic cancer is currently impossible because of poor delivery of vector to target sites. Modification of viral vectors to target advanced cancer has long been a challenge. In this study, we aimed to redirect adenovirus tropism to infect prostate cancer cells via alpha6beta1 integrins, whose expression is upregulated during prostate cancer progression. To ablate normal mechanisms of infection and provide a framework for attachment of targeting ligands, viruses were non-genetically modified with pHPMA-ONp polymer. Addition of polymer-coated virus to prostate cells showed significantly reduced transgene expression compared with unmodified virus. To restore infectivity, an alpha6-integrin binding peptide (-SIKVAV-) derived from laminin was incorporated onto the surface of the polymer-coated viruses. Photon correlation spectroscopic analysis revealed a small increase in the mean diameter of the particles following retargeting. Addition of -SIKVAV- peptide restored virus infectivity of PC-3 cells in a ligand concentration-dependent manner that was significantly improved following removal of unincorporated polymer and peptide. Competition assays using cells preincubated with Ad5 fiber protein or free -SIKVAV- peptide confirmed that entry of retargeted viruses was mediated via the incorporated ligand. Application of retargeted viruses to a panel of human cell lines revealed varying levels of transduction efficiency. Flow cytometric analysis of cells using anti-alpha6 integrin and anti-beta1 integrin antibodies demonstrated that for prostate cells, greater transduction efficiency correlated with higher levels of expression of both integrin subunits. Furthermore with the exception of LNCaP cells, increased alpha6beta1 integrin expression correlated with advanced disease. Intravenous administration of retargeted viruses to tumor-bearing mice resulted in slower plasma clearance and greatly reduced liver tropism, and hence toxicity compared with unmodified virus, while maintaining reporter gene expression in the tumor. The data suggest that YESIKVAVS-retargeted viruses have potential for systemic delivery for the treatment of metastatic disease.
Similar articles
- SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway.
Freitas VM, Vilas-Boas VF, Pimenta DC, Loureiro V, Juliano MA, Carvalho MR, Pinheiro JJ, Camargo AC, Moriscot AS, Hoffman MP, Jaeger RG. Freitas VM, et al. Am J Pathol. 2007 Jul;171(1):124-38. doi: 10.2353/ajpath.2007.051264. Am J Pathol. 2007. PMID: 17591960 Free PMC article. - Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
Green NK, Morrison J, Hale S, Briggs SS, Stevenson M, Subr V, Ulbrich K, Chandler L, Mautner V, Seymour LW, Fisher KD. Green NK, et al. J Gene Med. 2008 Mar;10(3):280-9. doi: 10.1002/jgm.1121. J Gene Med. 2008. PMID: 18214996 - Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells.
Stevenson M, Boos E, Herbert C, Hale A, Green N, Lyons M, Chandler L, Ulbrich K, van Rooijen N, Mautner V, Fisher K, Seymour L. Stevenson M, et al. Gene Ther. 2006 Feb;13(4):356-68. doi: 10.1038/sj.gt.3302655. Gene Ther. 2006. PMID: 16355117 - Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
Stepanenko AA, Chekhonin VP. Stepanenko AA, et al. Virus Res. 2018 Sep 15;257:40-51. doi: 10.1016/j.virusres.2018.08.012. Epub 2018 Aug 17. Virus Res. 2018. PMID: 30125593 Review. - Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ, Fooks AR. Silman NJ, et al. Curr Opin Mol Ther. 2000 Oct;2(5):524-31. Curr Opin Mol Ther. 2000. PMID: 11249755 Review.
Cited by
- Chitosan modification of adenovirus to modify transfection efficiency in bovine corneal epithelial cells.
Wang IJ, Jhuang MC, Chen YH, Yeh LK, Liu CY, Young TH. Wang IJ, et al. PLoS One. 2010 Aug 10;5(8):e12085. doi: 10.1371/journal.pone.0012085. PLoS One. 2010. PMID: 20711466 Free PMC article. - Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic.
Sarkar S, Quinn BA, Shen XN, Dash R, Das SK, Emdad L, Klibanov AL, Wang XY, Pellecchia M, Sarkar D, Fisher PB. Sarkar S, et al. Oncotarget. 2015 May 10;6(13):10712-27. doi: 10.18632/oncotarget.3544. Oncotarget. 2015. PMID: 25926554 Free PMC article. - Laminin-111-derived peptides and cancer.
Kikkawa Y, Hozumi K, Katagiri F, Nomizu M, Kleinman HK, Koblinski JE. Kikkawa Y, et al. Cell Adh Migr. 2013 Jan-Feb;7(1):150-256. doi: 10.4161/cam.22827. Epub 2012 Dec 21. Cell Adh Migr. 2013. PMID: 23263633 Free PMC article. Review. - Adenovirus receptors and their implications in gene delivery.
Sharma A, Li X, Bangari DS, Mittal SK. Sharma A, et al. Virus Res. 2009 Aug;143(2):184-94. doi: 10.1016/j.virusres.2009.02.010. Epub 2009 Feb 26. Virus Res. 2009. PMID: 19647886 Free PMC article. Review. - Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.
Kasala D, Yoon AR, Hong J, Kim SW, Yun CO. Kasala D, et al. Nanomedicine (Lond). 2016 Jul;11(13):1689-713. doi: 10.2217/nnm-2016-0060. Epub 2016 Jun 27. Nanomedicine (Lond). 2016. PMID: 27348247 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- BB/C515871/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BBS/B/03599/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- G0700166/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical